Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04709731
Title Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia (CarPAs)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Associazione Italiana Pazienti Leucemia Mieloide Cronica
Indications

chronic myeloid leukemia

Therapies

Ponatinib

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.